Adenosine, a potent natural suppressor of arachidonic acid release and leukotriene biosynthesis in human neutrophils

American Journal of Respiratory and Critical Care Medicine

Volumn 161, Issue 2 II, 2000, Pages

  Flamand, Nicolas ^b   Boudreault, Sylvie ^b   Picard, Serge ^b   Austin, Michèle ^b   Surette, Marc E ^b   Plante, Hendrick ^b   Krump, Eric ^b   Vallée, Marie Josée ^b   Gilbert, Caroline ^b   Naccache, Paul ^b   Laviolette, Michel ^b   Borgeat, Pierre ^a  

^a LAVAL UNIVERSITY   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ARACHIDONIC ACID; LEUKOTRIENE;

ALLERGY; BIOSYNTHESIS; DOWN REGULATION; IMMUNOMODULATION; INFLAMMATION; NEUTROPHIL; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW;

EID: 0034011526     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.161.supplement_1.ltta-18     Document Type: Review

References (51)

1. Hay, D. W. P., T. J. Torphy, and B. J. Undem. 1995. Cysteinyl leukotrienes in asthma: old mediators up to new tricks. Trends Pharmacol. Sci. 16:304-309.
2. Borgeat, P., and B. Samuelsson. 1979. Arachidonic acid metabolism in polymorphonuclear leukocytes: effects of ionophore A23187. Proc. Natl. Acad. Sci. U.S.A. 76:2148-2152.
3. Clancy, R. M., C. A. Dahinden, and T. E. Hugli. 1983. Arachidonate metabolism by human polymorphonuclear leukocytes stimulated by N-formyl-Met-Leu-Phe or complement component C5a is independent of phospholipase activation. Proc. Natl. Acad. Sci. U.S.A. 80: 7200-7204.
4. 2+ ionophore A23187. Biochem. J. 280:379-385.
5. 2, 5-lipoxygenase and 5-lipoxygenase-activating protein at the nuclear membrane of A23187-stimulated human neutrophils. Eur. J. Biochem. 238:250-258.
6. Woods, J. W., J. F. Evans, D. Ethier, S. Scott, P. J. Vickers, L. Hearn, J. A. Heibein, S. Charleson, and I.I. Singer. 1993. 5-Lipoxygenase and 5-lipoxygenase activating protein are localized in the nuclear envelope of activated human leukocytes. J. Exp. Med. 178:1935-1946.
7. 4 or its omega-metabolites. Biochem. J. 241:55-62.
8. Silberstein, D. S., W. F. Owen, J. C. Gasson, J. F. DiPersio, and D. W. Golde. 1986. Enhancement of human eosinophil cytotoxicity and leukotriene synthesis by biosynthetic (recombinant) granulocyte-macrophage colony-stimulating factor. J. Immunol. 137:3290-3294.
9. 4 synthesis. J. Immunol. 140:4315-4322.
10. Dahinden, C. A., J. Zingg, F. E. Maly, and A. L. DeWeck. 1988. Leukotriene production in human neutrophils primed by recombinant human granulocyte/macrophage colony-stimulating factor and stimulated with the complement component C5a and FMLP as second signals. J. Exp. Med. 167:1281-1295.
11. 4 by human neutrophils in response to platelet-activating factor-enhancement of both arachidonic acid availability and 5-lipoxygenase activation. J. Immunol. 146:1204-1211.
12. Krump. E., and P. Borgeat. 1994. Kinetics of 5-lipoxygenase activation, arachidonic acid release, and leukotriene synthesis in human neutrophils: effects of granulocyte-macrophage colony-stimulating factor. Biochim. Biophys. Acta 1213:135-139.
13. Surette, M. E., R. Palmantier, J. Gosselin, and P. Borgeat. 1993. Lipopolysaccharides prime whole human blood and isolated neutrophils for the increased synthesis of 5-lipoxygenase products by enhancing arachidonic acid availability-involvement of the CD 14 antigen. J. Exp. Med. 178:1347-1355.
14. 4 release from activated neutrophils. Proc. Natl. Acad. Sci. U.S.A. 80:4349-4353.
15. Fonteh, A. N., J. D. Winkler, T. J. Torphy, J. Heravi, B. J. Undem, and F. H. Chilton. 1993. Influence of isoproterenol and phosphodiesterase inhibitors on platelet-activating factor biosynthesis in the human neutrophils. J. Immunol. 151:339-350.
16. Cronstein, B. N. 1994. Adenosine, an endogenous antiinflammatory agent. J. Appl. Physiol. 76:5-13.
17. Le Vraux, V., Y. L. Chen, I. Masson, M. De Sousa, J. P. Giroud, I. Florentin, and L. Chauvelot-Moachon. 1993. Inhibition of human monocyte TNF-production by adenosine receptor agonists. Life Sci. 52: 1917-1924.
18. Bouma, M. G., R. K. Stad, F. A. J. Vandenwildenberg, and W. A. Buurman. 1994. Differential regulatory effects of adenosine on cytokine release by activated human monocytes. J. Immunol. 153:4159-4168.
19. Parmely, M. J., W. W. Zhou, I. C. K. Edwards, D. R. Borcherding, R. Silverstein, and D. C. Morrison. 1993. Adenosine and a related carbocyclic nucleoside analogue selectively inhibit tumor necrosis factor-α production and protect mice against endotoxin challenge. J. Immunol. 151:389-396.
20. Moroz, C., and R. H. Stevens. 1980. Suppression of immunoglobulin production in normal human B lymphocytes by two T-cell subsets distinguished following in vitro treatment with adenosine. Clin. Immunol. Immunopathol. 15:44-51.
21. Wolberg, G., T. P. Zimmerman, K. Hienstra, M. Winston, and L. C. Chu. 1975. Adenosine inhibition of lymphocyte-mediated cytolysis: possible role of cyclic adenosine monophosphate. Science 187:957-959.
22. Green, P. G., A. I. Basbaum, C. Helms, and J. D. Levine. 1991. Purinergic regulation of bradykinin-induced plasma extravasation and adjuvant-induced arthritis in the rat. Proc. Natl. Acad. Sci. U.S.A. 88:4162-4165.
23. Grisham, M. B., L. A. Hernandez, and D. N. Granger. 1989. Adenosine inhibits ischemia-reperfusion-induced leukocyte adherence and extravasation. Am. J. Physiol. 257:H1334-H1339.
24. Kaminski, P. M., and K. G. Proctor. 1989. Attenuation of no-reflow phenomenon, neutrophil activation, and reperfusion injury in intestinal microcirculation by topical adenosine. Cir. Res. 65:426-435.
25. Forman, M. B., C. E. Velasco, and E. K. Jackson. 1993. Adenosine attenuates reperfusion injury following regional myocardial ischemia. Cardiovasc. Res. 27:9-17.
26. Marts, B. C., L. J. Baudendistal, K. S. Naunheim, and T. E. Dahms. 1993. Protective effect of 2-chloro-adenosine on lung ischemia reperfusion injury. J. Surg. Res. 54:523-529.
27. Schrier, D. J., M. E. Lesch, C. D. Wright, and R. B. Gilbertsten. 1990. The antiinflammatory effects of adenosine receptor agonists on the carrageenan-induced pleural inflammatory response in rats. J. Immunol. 145:1874-1879.
28. Cronstein, B. N., D. Naime, and E. Ostad. 1993. The antiinflammatory mechanism of methotrexate: increased adenosine release at inflamed sites diminished leukocyte accumulation in an in vivo model of inflammation. J. Clin. Invest. 92:2675-2682.
29. Iannone, M. A., G. Wolberg, and T. Zimmerman. 1989. Chemotactic peptide induces cAMP elevation in human neutrophils by amplification of the adenylate cyclase response to endogenously produced adenosine. J. Biol. Chem. 264:20177-20180.
30. Cronstein, B. N., K. A. Haines, S. L. Kolasinski, and J. Reibman. 1992. Occupancy of Gαs-linked receptors uncouples chemoattractant receptors from their stimulus-transduction mechanisms in the neutrophil. Blood 80:1052-1057.
31. 2 receptor occupancy regulates stimulated neutrophil function via activation of a serine/threonine protein phosphatase. J. Biol. Chem. 271:17114-17118.
32. 2 receptors. Cell. Signal. 4:543-551.
33. 2 with membrane in the macrophage cell line Raw 264.7. J. Biol. Chem. 265:5409-5413.
34. Rouzer, C. A., and B. Samuelsson. 1985. On the nature of the 5-lipoxygenase reaction in human leukocytes enzyme purification and requirement for multiple stimulatory factors. Proc. Natl. Acad. Sci. U.S.A. 82:6040-6044.
35. Collis, M. G., and S. M. O. Hourani. 1993. Adenosine receptor subtypes. Trends Pharmacol. Sci. 14:360-366.
36. 4 synthesis in whole blood ex vivo. Br. J. Pharmacol 117:1639-1644.
37. Palmantier, R., M. E. Surette, A. Sanchez, P. Braquet, and P. Borgeat. 1994. Priming for the synthesis of 5-lipoxygenase products in human blood ex vivo by human granulocyte-macrophage colony-stimulating factor and tumor necrosis factor-alpha. Lab. Invest. 70:696-704.
38. Borgeat, P., S. Picard, P. Vallerand, S. Bourgoin, A. Odeimat. P. Sirois, and P. E. Poubelle. 1990. Automated on-line extraction and profiling of lipoxygenase products of arachidonic acid by high-performance liquid chromatography. Methods Enzymol. 187:98-116.
39. Surette, M. E., A. Odeimat, R. Palmantier, S. Marleau, P. E. Poubelle, and P. Borgeat. 1994. Reverse phase HPLC analysis of arachidonic acid metabolites in plasma after stimulation of whole blood ex vivo. Anal. Biochem. 216:392-400.
40. 3 receptor stimulation inhibits migration of human eosinophils. J. Leukocyte Biol. 62:465-468.
41. Eppell, B. A., A. B. Newell, and E. J. Brown. 1989. Adenosine receptors are expressed during differentiation of monocytes to macrophages in vitro. J. Immunol. 143:4141-4145.
42. 2+-influx in human neutrophils. Biochem. J. 297:595-601.
43. 2. J. Biol. Chem. 272:16709-16712.
44. 4 in chemotactic peptide-stimulated human neutrophils. FASEB J. 12:1521-1531.
45. 2 is phosphorylated and activated by MAP kinase. Cell 72:269-278.
46. Chilton, F. H., A. N. Fonteh, C. M. Sung, D. M. B. Hickey, T. J. Torphy, R. J. Mayer, L. A. Marshall, J. D. Heravi, and J. D. Winkler. 1995. Inhibitors of CoA-independcnt transacylase block the movement of arachidonate into 1-ether-linked phospholipids of human neutrophils. Biochemistry 34:5403-5410.
47. 2 expressed in insect cells and present in human monocytes. J. Biol. Chem. 271: 6987-6997.
48. van Waeg, G., and G. Van den Berghe. 1991. Purine catabolism in polymorphonuclear neutrophils-phorbol myristate acetate-induced accumulation of adenosine owing to inactivation of extracellularly released adenosine deaminase. J. Clin. Invest. 87:305-312.
49. 4 biosynthesis by endogenous adenosine in ligand-activated human neutrophils. J. Exp. Med 186:1401-1406.
50. Moser, G. H., J. Schrader, and A. Deussen. 1989. Turnover of adenosine in plasma of human and dog blood. Am. J. Physiol. 256:C799-C806.
51. Gadangi, P., M. Longaker, D. Naime, R. I. Levin, P. A. Recht, M. C. Montesinos, M. T. Buckly, G. Carlin, and B. N. Cronstein. 1996. The anti-inflammatory mechanism of sulfasalazine is related to adenosine release at inflamed sites. J. Immunol. 156:1937-1941.